Stocks and Investing Stocks and Investing
Tue, June 27, 2023

Kennen MacKay Maintained (AGIO) at Buy with Increased Target to $42 on, Jun 27th, 2023


Published on 2024-10-28 04:31:24 - WOPRAI, Kennen MacKay
  Print publication without navigation


Kennen MacKay of RBC Capital, Maintained "Agios Pharmaceuticals, Inc." (AGIO) at Buy with Increased Target from $40 to $42 on, Jun 27th, 2023.

Kennen, nor any peers, have made any analyst calls on AGIO in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Contributing Sources